We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Octopus Group

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Buoyed by Rising Chronic Diseases, Global Clinical Diagnostics Market to Approach USD 100 Billion Mark by 2028

By LabMedica International staff writers
Posted on 29 Aug 2022
Print article
Image: The global clinical diagnostic market is expected to grow at a CAGR of 5.8% from 2022 to 2028 (Photo courtesy of Unsplash)
Image: The global clinical diagnostic market is expected to grow at a CAGR of 5.8% from 2022 to 2028 (Photo courtesy of Unsplash)

The adoption of sedentary lifestyles has led to an increase in the prevalence of infectious and chronic diseases such as diabetes, high blood pressure, lipid disorders, and cardiovascular diseases. Patients suffering from chronic kidney disease and cancer disorders require the urgent intervention of clinical diagnostics. The benefits of clinical diagnostics such as quick test results, easy testing procedure, seamless sample procurement, and less pain are driving the demand for diagnostics instruments. Additionally, the onset of the pandemic has led to an increase in lab testing in order to keep pace with rising cases of COVID-19 across the world. The global clinical diagnostic market is projected to grow at a CAGR of 5.8% from 2022 to 2028 to reach USD 98 billion in 2028, driven by the rising prevalence of chronic diseases, a gradual shift towards automated testing systems, and expansion of point-of-care testing.

These are the latest findings of Valuates Reports (Bangalore, India), a market research firm.

Automated equipment can complete diagnosis of diseases within very less time, leading to better treatment within a short period. However, manual diagnostic processes are prone to human errors as test tubes and pipettes can be accidentally dropped or samples may be contaminated. Robotic diagnoses maintain zero deviation from their predefined tasks and are less likely to be subject to unexpected scenarios, thereby preventing equipment damage. This is likely to boost the growth of the clinical diagnostics market. Moreover, instruments such as rapid testing kits do not require any specialized training as they can be used by medical workers and non-volunteers easily. Self-testing is also feasible and is useful in areas with limited resources or inadequate access to specialized labs.

Point-of-care testing is growing in popularity due to the rising pressure on healthcare facilities for faster turnaround of laboratory results. A wide variety of testing devices have been developed that are portable, require less blood, and feature computerized information management systems. The near-patient treatment of strokes, infectious diseases, and cancer are now possible as the key players in the clinical diagnostic market are making huge investments in enhancing the specificity and sensitivity of testing devices using smaller specimen samples. For instance, a point-of-care blood analyzer can run multiple tests on a single cartridge for cardiac signals, chemistries, coagulation, electrolytes, hematology, and blood gasses, leading to rapid clinical decision-making, monitoring, and effective resource utilization. This is expected to drive the expansion of the clinical diagnostics market over the coming years. Moreover, a number of laboratories have expanded to monitor the epidemiological situation of COVID-19 infection. The total number of performed tests and positivity ratio has been increasing significantly within a shorter time period between sampling, testing, and reporting. This is likely to lead to a surge in the growth of the clinical diagnostics market.

Based on product type, the instruments segment is anticipated to record the highest growth in the clinical diagnostics market due to increasing initiatives by public and private players in expanding laboratory infrastructure and the introduction of innovative testing kits for rapid diagnosis of diseases like HIV, and diabetes, etc. Based on application, the hospital segment is expected to be the most lucrative in the clinical diagnostics market due to the rising patient admission rate, expansion of hospital laboratories worldwide, and huge government efforts to ensure proper availability of modern treatment and diagnostic technologies across hospitals.

Geographically, North America is expected to dominate the global clinical diagnostic market share due to its high geriatric population base, rising awareness of laboratory tests, well-established healthcare infrastructure, and the presence of cost-effective diagnostic kits for diseases such as AIDs, and hepatitis C, etc. On the other hand, the clinical diagnostic market in Asia-Pacific is anticipated to grow at the fastest pace due to potential opportunities in the region created by unmet clinical testing needs and increasing demand for healthcare services in its emerging economies such as China, India, etc.



Gold Supplier
Colon Cancer Mutation Panel
UltraSEEK Colon Panel
Fecal Bacterial Test
CLART EnteroBac
Lipase Assay
Lipase Assay
Fecal Calprotectin Testing Reagent
OC-FCa Reagent

Print article


Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: Researchers have identified the origin of subset of autoantibodies that worsen lupus (Photo courtesy of Pexels)

Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs when the body's antibodies, which usually protect against infections, attack healthy cells and proteins. These autoantibodies can... Read more


view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more


view channel
Image: Use of DBS samples can break barriers in hepatitis C diagnosis and treatment for populations at risk (Photo courtesy of Pexels)

DBS-Based Assay Effective in Hepatitis C Diagnosis and Treatment for At Risk Populations

In a bid to eliminate viral hepatitis as a public health threat by 2030, the World Health Organization (WHO) has put forth a proposed strategy. To this end, researchers at the Germans Trias i Pujol Research... Read more


view channel
Image: New research has opened a path for fast and accurate cancer diagnosis (Photo courtesy of Imagene)

AI-Based Image Analysis Software Profiles Cancer Biomarkers in Real Time

Lung cancer is the most widespread type of cancer worldwide, resulting in approximately 1.76 million fatalities annually. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer diagnoses... Read more


view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.